Molecular Imaging Biomarkers for Oncology Clinical Trials

被引：55
|
作者：
Mankoff, David A. [1 ]
Pryma, Daniel A. [1 ]
Clark, Amy S. [2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2014年 / 55卷 / 04期
关键词：
cancer biomarkers; clinical trials; cancer therapy; BREAST-CANCER; FDG-PET; TRASTUZUMAB; CRITERIA;
D O I：
10.2967/jnumed.113.126128
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This "Focus on Molecular Imaging" article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging.
引用
收藏
页码：525 / 528
页数：4
相关论文
共 50 条
  • [1] MR Imaging Biomarkers in Oncology Clinical Trials
    Abramson, Richard G.
    Arlinghaus, Lori R.
    Dula, Adrienne N.
    Quarles, C. Chad
    Stokes, Ashley M.
    Weis, Jared A.
    Whisenant, Jennifer G.
    Chekmenev, Eduard Y.
    Zhukov, Igor
    Williams, Jason M.
    Yankeelov, Thomas E.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2016, 24 (01) : 11 - +
  • [2] Opportunities and pitfalls in developing imaging biomarkers (IB) in oncology clinical trials
    Collette, S.
    Liu, Y.
    Collette, L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S200 - S200
  • [3] Imaging of molecular target modulation in oncology: Challenges of early clinical trials
    Cullinane C.
    Solomon B.
    Hicks R.J.
    Clinical and Translational Imaging, 2014, 2 (1) : 5 - 12
  • [4] Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials
    Van Heertum, Ronald L.
    Scarimbolo, Robert
    Ford, Robert
    Berdougo, Eli
    O'Neal, Michael
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5215 - 5223
  • [5] Biomarkers and Precision Medicine in Oncology Practice and Clinical Trials
    Perez, Edith A.
    ADVANCING THE SCIENCE OF CANCER IN LATINOS, 2020, : 113 - 123
  • [6] A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation
    Chauvie, Stephane
    Mazzoni, Lorenzo Nicola
    O'Doherty, Jim
    TOMOGRAPHY, 2023, 9 (05) : 1876 - 1902
  • [7] Quantitative Imaging Assessment for Clinical Trials in Oncology
    Hersberger, Katherine E.
    Mendiratta-Lala, Mishal
    Fischer, Rocky
    Kaza, Ravi K.
    Francis, Isaac R.
    Olszewski, Mirabella S.
    Harju, John F.
    Shi, Wei
    Manion, Frank J.
    Al-Hawary, Mahmoud M.
    Sahai, Vaibhav
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (12): : 1505 - +
  • [8] Molecular profiling and biomarkers in oncology clinical researches
    Ru, Qinhua Cindy
    PROGRESS ON POST-GENOME TECHNOLOGIES, 2007, : 40 - 40
  • [9] Molecular and cellular biomarkers for angiogenesis in clinical oncology
    Bertolini, Francesco
    Mancuso, Patrizia
    Shaked, Yuval
    Kerbel, Robert S.
    DRUG DISCOVERY TODAY, 2007, 12 (19-20) : 806 - 812
  • [10] Molecular imaging in clinical trials
    Debra Josephs
    James Spicer
    Michael O’Doherty
    Targeted Oncology, 2009, 4 : 151 - 168
12345